DEUTSCHE BANK AG\ - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 81 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$108,000
+80.0%
42,641
+43.7%
0.00%
Q1 2020$60,000
-28.6%
29,673
-25.3%
0.00%
Q4 2019$84,000
+320.0%
39,708
+176.9%
0.00%
Q3 2019$20,000
-87.9%
14,339
-64.2%
0.00%
Q2 2019$165,000
-50.7%
40,024
-50.3%
0.00%
Q1 2019$335,000
+148.1%
80,598
+68.9%
0.00%
Q4 2018$135,000
-91.6%
47,726
-70.4%
0.00%
Q3 2018$1,610,000
+57.4%
161,119
+11.1%
0.00%
Q2 2018$1,023,000
-22.4%
144,993
-58.0%
0.00%
-100.0%
Q1 2018$1,318,000
-61.2%
345,284
-17.0%
0.00%
-50.0%
Q4 2017$3,396,000
+339500.0%
416,215
+208007.5%
0.00%
Q3 2017$1,000200
+25.8%
0.00%
Q2 2017$0159
-68.2%
0.00%
Q1 2017$0
-100.0%
500
-50.7%
0.00%
Q4 2015$7,000
+133.3%
1,015
+238.3%
0.00%
Q2 2015$3,000
+50.0%
300
+18.1%
0.00%
Q4 2014$2,0000.0%254
-36.5%
0.00%
Q3 2014$2,0004000.00%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
VR Adviser, LLC 6,502,840$13,201,0003.58%
Lion Point Capital, LP 6,374,740$12,940,0003.42%
Granite Point Capital Management, L.P. 1,889,100$3,835,0002.17%
Bain Capital Life Sciences Investors, LLC 5,942,735$12,064,0002.04%
Asymmetry Capital Management, L.P. 855,318$1,736,0001.90%
ACUTA CAPITAL PARTNERS, LLC 1,038,000$2,107,0001.02%
Bleichroeder LP 1,250,000$2,538,0000.66%
Boxer Capital, LLC 4,800,000$9,744,0000.66%
Avoro Capital Advisors LLC 6,200,000$12,586,0000.42%
Islet Management, LP 1,000,000$2,030,0000.30%
View complete list of MARINUS PHARMACEUTICALS INC shareholders